Susquehanna International Group, LLP Gritstone Bio, Inc. Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 596,055 shares of GRTS stock, worth $131,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares

596,055

Previous 364,200 63.66%

Holding current value

$131,132

Previous $935,000 60.53%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$0.62 - $2.35 $369,554 - $1.4 Million	596,055 New	596,055 $369,000
Q4 2023 Feb 14, 2024	SELL	$1.28 - $2.85 $107,239 - $238,775	-83,781 Reduced 34.83%	156,756 $319,000
Q3 2023 Nov 14, 2023	BUY	$1.19 - $2.26 $78,122 - $148,366	65,649 Added 37.54%	240,537 $413,000
Q2 2023 Aug 11, 2023	SELL	$1.66 - $3.03 $779,052 - $1.42 Million	-469,309 Reduced 72.85%	174,888 $341,000
Q1 2023 May 16, 2023	BUY	$2.13 - $3.74 $441,751 - $775,657	207,395 Added 47.48%	644,197 $1.79 Million
Q4 2022 Feb 14, 2023	BUY	$2.17 - $3.92 $829,595 - $1.5 Million	382,302 Added 701.47%	436,802 $1.51 Million
Q3 2022 Nov 14, 2022	SELL	$2.46 - $4.75 $172,165 - $332,433	-69,986 Reduced 56.22%	54,500 $140,000
Q2 2022 Aug 15, 2022	SELL	$1.77 - $4.34 $51,767 - $126,931	-29,247 Reduced 19.02%	124,486 $301,000
Q1 2022 May 16, 2022	SELL	$4.03 - $12.19 $538,291 - $1.63 Million	-133,571 Reduced 46.49%	153,733 $633,000
Q4 2021 Feb 14, 2022	BUY	$8.76 - $13.71 $31,378 - $49,109	3,582 Added 1.26%	287,304 $3.7 Million
Q3 2021 Nov 15, 2021	BUY	$6.41 - $13.54 $1.67 Million - $3.53 Million	260,343 Added 1113.58%	283,722 $3.06 Million
Q2 2021 Aug 11, 2021	BUY	$8.13 - $10.2 $190,071 - $238,465	23,379 New	23,379 $213,000
Q2 2020 Aug 14, 2020	SELL	$5.69 - $8.17 $56,945 - $81,765	-10,008 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.47 - $11.3 $54,743 - $113,090	10,008 New	10,008 $58,000
Q4 2019 Feb 14, 2020	SELL	$7.07 - $11.61 $78,151 - $128,336	-11,054 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$8.45 - $12.28 $18,978 - $27,580	-2,246 Reduced 16.89%	11,054 $95,000
Q2 2019 Aug 16, 2019	BUY	$9.2 - $15.7 $122,359 - $208,810	13,300 New	13,300 $148,000

Others Institutions Holding GRTS

# of Institutions

Shares Held

37.5M

Call Options Held

1.46M

Put Options Held

168K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $16.1M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Gritstone Bio, Inc. Transaction History